GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apollomics Inc (NAS:APLMW) » Definitions » Accounts Payable & Accrued Expense

Apollomics (Apollomics) Accounts Payable & Accrued Expense : $9.16 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Apollomics Accounts Payable & Accrued Expense?

Apollomics's quarterly accounts payable & accrued expense increased from Dec. 2022 ($11.68 Mil) to Jun. 2023 ($13.75 Mil) but then declined from Jun. 2023 ($13.75 Mil) to Dec. 2023 ($9.16 Mil).

Apollomics's annual accounts payable & accrued expense increased from Dec. 2021 ($11.40 Mil) to Dec. 2022 ($11.68 Mil) but then declined from Dec. 2022 ($11.68 Mil) to Dec. 2023 ($9.16 Mil).

Apollomics Accounts Payable & Accrued Expense Historical Data

The historical data trend for Apollomics's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apollomics Accounts Payable & Accrued Expense Chart

Apollomics Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Accounts Payable & Accrued Expense
8.32 11.40 11.68 9.16

Apollomics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Accounts Payable & Accrued Expense Get a 7-Day Free Trial 11.40 12.04 11.68 13.75 9.16

Apollomics Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Apollomics (Apollomics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apollomics Inc (NAS:APLMW) » Definitions » Accounts Payable & Accrued Expense
Comparable Companies
ATHA STTK ACXP CARA TLSA ORMP IMMX CCCC GTHX GBIO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
APLM:USA
Address
989 East Hillsdale Boulevard, Suite 220, Foster, CA, USA, 94404
Website
https://www.apollomicsinc.com
Apollomics Inc is an innovative clinical-stage biotechnology company. It is is focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. It has a pipeline of 9 drug candidates across multiple programs, 6 of which are in the clinical stage of development.